4 Kingdom Street
Floor 4 Unit 4B Paddington Central
London W2 6BD
United Kingdom
44 20 4551 8888
https://www.etherapeutics.co.uk
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 39
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Ahmad Ali Mortazavi | CEO & Director | 348k | N/A | 1971 |
Mr. Michael Anthony Bretherton ACA, B.A. | Acting Interim CFO & Director | 53k | N/A | 1955 |
Dr. Laura Roca-Alonso Ph.D. | Chief Operating & Bus. Officer | N/A | N/A | N/A |
Mr. Alan Whitmore B.Sc., Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Ms. Sarah Clare | Director of Fin. & Compliance | N/A | N/A | N/A |
Ms. Alison Gallafent | Chief Intellectual Property Officer | N/A | N/A | N/A |
Mr. Ankit Sharma | Head of Software Engineering | N/A | N/A | N/A |
Mr. Graham Craggs | Head of Therapeutic Discovery | N/A | N/A | N/A |
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.
e-Therapeutics plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.